EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Ajoy Gopinath Prabhu
Symbiotica Speciality Ingredients Sdn. Bhd.
Ajoy Gopinath Prabhu, the CEO of Symbiotica Speciality Ingredients Sdn. Bhd., founded the company in 2001 to manufacture active pharmaceutical ingredients (APIs). Since its inception, Symbiotica Speciality Ingredients Sdn. Bhd. has pioneered steroidal API production in Malaysia, expanding from kilogram-scale operations to offering over 70 APIs with a capacity of 70 MT, making it the largest in ASEAN. With a reach in 70 countries and consistent regulatory approvals from the National Pharmaceutical Regulatory Agency (NPRA), the United States Food and Drug Administration (US FDA), and Pharmaceuticals and Medical Devices Agency (PMDA), Symbiotica Speciality Ingredients Sdn. Bhd. specializes in delivering high-quality APIs, facilitating access to essential medicines. Committed to ethical growth, the company nurtures local talent, drives innovation through academic collaboration, and promotes sustainability. Symbiotica Speciality Ingredients Sdn. Bhd. is focused on developing new products, obtaining regulatory approvals, and building strategic partnerships, including potential mergers and acquisitions. Ajoy Gopinath Prabhu aims to establish Symbiotica Speciality Ingredients Sdn. Bhd. as a globally trusted Malaysian name for high-quality APIs, fostering scientific excellence and responsible growth that benefits patients, partners, and communities across ASEAN and beyond.